Tag: Zoll

FDA Approves Next-Generation ZOLL® TherOx System for Widowmaker Heart Attack Patients

First and Only Treatment to Reduce Heart Muscle Damage Following Angioplasty and Stenting CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced today it has received U.S. Food and Drug Administration […]

ZOLL Acquires Mobilize RRS LLC.

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced it has acquired substantially all of the assets of Mobilize RRS LLC., of Pittsford, N.Y., a privately held company that markets […]

Aurora Resurgence Announces Sale of Cardiac Science Corporation to ZOLL Medical Corporation

LOS ANGELES, June 11, 2019 /PRNewswire/ — Aurora Resurgence, a Los Angeles-based private equity firm, today announced that its affiliate has entered into a definitive agreement to sell Cardiac Science Corporation (“Cardiac Science” or “CSC”), a leading provider of automated external defibrillators (“AEDs”), related […]

Zoll Introduces New Technology to Improve the Management of Acute Heart Failure Patients

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced the launch of and first patient prescription for the ZOLL µCor™ (pronounced “Micro Core”) Heart Failure and Arrhythmia Management System (HFAMS), […]